Informing an investment case for Japanese encephalitis vaccine introduction in Bangladesh
Science Advances · 2024
DOI: 10.1126/sciadv.adp1657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Mariana Perez Duque und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pathogen Dynamics Group, Department of Genetics, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Encephalitis, Japanese, Japanese Encephalitis Vaccines, Encephalitis Virus, Japanese. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCPDCID CDC HHS.
Abstract (Originalsprache)
Japanese encephalitis virus (JEV) is a major threat to human health. Bangladesh is considering introducing a JEV vaccine; however, the investment case is hampered by a limited understanding of key aspects of JEV ecology. We conducted a seroprevalence study in a high-incidence region using an assay that limits cross-reactivity with dengue virus. We also trapped mosquitoes and collected information about potential host species. We used mathematical models to recover risk factors for infection and underlying probabilities of severe disease and death. We observed 19.0% [95% confidence interval (CI):17.1 to 21.1] of JEV antibodies. On average, 0.7% (95% CI: 0.2 to 2.0) of the susceptible population gets infected yearly, with pig proximity being the main human infection risk factor. Our traps captured 10 different mosquito species that have been linked with JEV transmission. We estimated that 1 in 1000 infections results in severe disease, 1 in 10,000 results in death, and 76% of severe cases are missed by surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pathogen Dynamics Group, Department of Genetics, University of Cambridge, Cambridge, UK.
- International Centre for Diarrheal Diseases Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
- Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, TN, USA.
- School of Population Health, University of New South Wales, Sydney, NSW, Australia.
- Institute for Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh.
- School of the Environment, The University of Queensland, Brisbane, QLD, Australia.
ORCID-Profile: Mariana Perez Duque, Abu M Naser, Kishor K Paul, Mahmudur Rahman, Mohammad S Alam, Hasan M Al-Amin, Mohammed Z Rahman, Mohammad E Hossain, Stephen P Luby, Simon Cauchemez, Jessica Vanhomwegen, Emily S Gurley, Henrik Salje
Förderung
- NCPDCID CDC HHS
Zitieren
APA
Duque, M. P., Naser, A. M., Dos Santos, G. R., O'Driscoll, M., Paul, K. K., Rahman, M., Alam, M. S., Al-Amin, H. M., Rahman, M. Z., Hossain, M. E., Paul, R. C., Luby, S. P., Cauchemez, S., Vanhomwegen, J., Gurley, E. S., & Salje, H. (2024). Informing an investment case for Japanese encephalitis vaccine introduction in Bangladesh. Science Advances. https://doi.org/10.1126/sciadv.adp1657
Vancouver
Duque MP, Naser AM, Dos Santos GR, O'Driscoll M, Paul KK, Rahman M, et al. Informing an investment case for Japanese encephalitis vaccine introduction in Bangladesh. Science Advances. 2024. doi:10.1126/sciadv.adp1657
BibTeX
@article{Duque2024,
author = {Duque, Mariana Perez and Naser, Abu M and Dos Santos, Gabriel Ribeiro and O'Driscoll, Megan and Paul, Kishor K and Rahman, Mahmudur and Alam, Mohammad S and Al-Amin, Hasan M and Rahman, Mohammed Z and Hossain, Mohammad E and Paul, Repon C and Luby, Stephen P and Cauchemez, Simon and Vanhomwegen, Jessica and Gurley, Emily S and Salje, Henrik},
title = {Informing an investment case for Japanese encephalitis vaccine introduction in Bangladesh},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adp1657}
}
EUVIMED